Non-HDL-cholesterol/apolipoprotein B ratio: A useful distinguishing feature in the screening for type III hyperlipoproteinemia

Journal of Clinical Lipidology

Volumn 4, Issue 2, 2010, Pages 99-104

  Murase, Toshio ^a,b   Okubo, Minoru ^a,b   Takeuchi, Ichiro ^c  

^a Okinaka Memorial Institute for Medical Research   (Japan)

^b TORANOMON HOSPITAL   (Japan)

^c Tokyo Metropolitan Health and Medical Treatment Corporation   (Japan)

Author keywords

Apolipoprotein B; Combined hyperlipoproteinemia; Dysbetalipoproteinemia; Dyslipidemia in hypothyroidism; Non HDL cholesterol; Type III hyperlipoproteinemia

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; NON HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERLIPOPROTEINEMIA TYPE 3; HYPOTHYROIDISM; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL;

ADULT; AGED; APOLIPOPROTEINS B; APOLIPOPROTEINS E; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHOLESTEROL; CHOLESTEROL, HDL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; HYPERLIPOPROTEINEMIA TYPE III; HYPOTHYROIDISM; MALE; MASS SCREENING; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; TRIGLYCERIDES;

EID: 77949825540     PISSN: 19332874     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacl.2010.01.004     Document Type: Article

References (16)

1. Mahley R.W., and Rall Jr. S.C. Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In: Scriber C.R., Beaudet A.L., Aly W.S., and Vallo O. (Eds). The Metabolic and Molecular Basis of Inherited Disease. 8th ed (2001), McGraw-Hill, New York, NY 2835-2855
2. Fredrickson D.S., Morganroth J., and Levy R.I. Type III hyperlipoproteinemia: analysis of two contemporary deficiencies. Ann Intern Med 82 (1975) 150-157
3. Blom D.J., O'Neill, and Marais A.D. Screening for dysbetalipoproteinemia by plasma cholesterol and apolipoprotein B concentrations. Clin Chem 51 (2005) 904-907
4. Sniderman A., Tremblay A., Bergeron J., Gagne C., and Couture P. Diagnosis of type III hyperlipoproteinemia from total cholesterol, triglyceride, and apolipoprotein B. J Clin Lipidol 1 (2007) 256-263
5. März W., Feussner G., Siekmeier R., et al. Apolipoprotein E to B ratio: a marker for type III hyperlipoproteinemia. Eur J Clin Chem Clin Biochem 31 (1993) 743-747
6. Toda Y., Kobayashi J., Higashikata T., et al. Detailed analysis of serum lipids and lipoproteins from Japanese type III hyperlipoproteinemia with apolipoprotein E2/2 phenotype. Clin Chim Acta 348 (2004) 35-40
7. Ishibashi S., Murase T., Yamada N., Tanaka K., Takaku F., and Sato K. Hyperlipidaemia in patients with hypopituitarism. Acta Endocrinol 110 (1985) 456-460
8. Murase T., Yamada N., and Uchimura H. Accumulation of intermediate density lipoprotein in the plasma of cholesterol-fed hypothyroid rats. Metabolism 32 (1983) 146-150
9. Okubo M., Aoyama Y., Harada K., et al. A novel apolipoprotein E2 variant, E2Toranomon (Q187E), identified in a type III hyperlipoproteinemia patient with coronary atherosclerosis. Atherosclerosis 140 (1988) 187-190
10. Arai T., Tsukada T., Murase T., and Matsumoto K. Particle size analysis of high density lipoproteins in patients with genetic cholesteryl ester transfer protein deficiency. Clin Chim Acta 301 (2000) 103-117
11. Yamada N., Murase T., Akanuma Y., Itakura H., and Kosaka K. Plasma apolipoprotein E levels in hypertriglyceridemia. Horm Metab Res 14 (1982) 303-306
12. Gotoda T., Yamada N., Kawamura M., et al. Heterogeneous mutations in the human lipoprotein lipase gene in patients with familial lipoprotein lipase deficiency. J Clin Invest 88 (1991) 1856-1864
13. +1 to C mutation in a donor splice site of intron 2 in the apolipoprotein (apo) C-II gene deficiency and apoE4 in a severely hypertriglyceridemic patient. Atherosclerosis 130 (1997) 153-160
14. Warnick G.R., Nauck M., and Refai N. Evaluation of methods for measurement of HDL-cholesterol: from ultracentrifugation to homogeneous assays. Clin Chem 47 (2001) 1579-1596
15. Ebara T., Murase T., and Okubo M. Pancreatitis caused by hypertriglyceridemia in a patient compound heterozygous for Leu334Phe and -514C→T in the hepatic lipase gene. Pancreas 38 (2009) 233-235
16. Okubo M., Ishihara M., Iwasaki T., et al. A novel APOA5 splicing mutation IVS2+1g>a in a Japanese chylomicronemia patient. Atherosclerosis 207 (2009) 24-25